When a request is declined, and why that can protect you
Legitimate reasons a service says no, and what you can do next.
Reviewed by the Reserve Meds clinical operations team on 18 October 2026. Sources accessed 18 October 2026.
The short answer
A careful service declines a request when it cannot be done safely and legally: for example, when there is no prescription, the medicine is investigational, the destination rules do not allow the route, or the medicine cannot be kept at the right temperature. A clear no, with the reason and the other options, protects you.
- No prescription: a prescription from your treating doctor is required.
- Investigational medicine: only available through a manufacturer program or a trial.
- Route not allowed: the destination country's rules come first.
- Safety: the medicine cannot be shipped or given safely.
Common, legitimate reasons to decline
- There is no prescription from the treating doctor. A legitimate seller of prescription medicines always requires one.[1]
- The medicine is not approved by the US FDA for the intended use, so it is investigational.
- The destination country's rules do not allow the route being asked for, or the hospital will not file the request.
- The medicine needs a temperature range or handling that cannot be guaranteed for the journey.
- The medicine must be given in a specialized center and cannot be supplied to a home or a general clinic.
Reserve Meds also keeps the right to decline requests, as our terms explain, and when we do, we explain why.
If the medicine is investigational
Investigational medicines are a different route. In the US, expanded access needs the agreement of a licensed physician, an Institutional Review Board and the company that makes the product; without the company's cooperation there is no access.[2]
FDA's criteria for expanded access include a serious or immediately life-threatening condition, no comparable or satisfactory alternative, and no possibility of joining a clinical trial.[3]
In Europe, compassionate use programmes are run by member states, and EMA notes that patients should always be considered for clinical trials first.[4]
If the route is not allowed
Rules for unregistered medicines are set by each destination country. In Bahrain, for example, NHRA Circular 41 of 2020 requires a hospital to obtain the authority's permission before it issues a purchase order for a non-registered medicine, and to transport and store the product in containers that follow the manufacturer's recommended conditions.[5]
Ask your treating hospital which route it can file. Sometimes a different route, such as a hospital request instead of a personal import, is possible.
If treatment must be given abroad
Some treatments are given only at specialized centers. If you consider travelling for treatment, the US CDC advises checking the qualifications of the clinician and the credentials of the facility, planning how you will communicate with the care team, and arranging follow-up care for when you return.[6]
Why a clear no is better than a vague yes
The World Health Organization estimates that at least 1 in 10 medicines in low- and middle-income countries is substandard or falsified, and notes that such products are often sold online or in informal markets and include life-saving treatments such as cancer therapies.[7]
A service that accepts every request, whatever the medicine or route, is taking risks with your health. A clear no, with a reason and next steps, lets you and your doctor move on to a route that can work.
How Reserve Meds helps
Reserve Meds is a digital health company. Medicines are supplied through a US-licensed pharmaceutical wholesale partner. We coordinate the route with your treating doctor and hospital, prepare the paperwork the regulator or hospital asks for, and arrange supply once approval is in place. Your doctor prescribes and makes every medical decision. You can ask us for our wholesale partner's licence details, and you get your quote and timeline estimate in writing before you commit.
We coordinate access to FDA-approved medicines only. Investigational medicines are only available through a manufacturer's expanded-access program requested by the treating physician; we can explain that route, but we do not supply them. Your coordination fee is quoted in writing for your case before you commit. No hidden charges. We give you a written timeline estimate for your case before you commit.
Ask us about a medicine
Tell us the medicine, your country and a WhatsApp or phone number. We reply within one business day. On WhatsApp we usually reply the same day.
Frequently asked questions
Why would a service decline my request?
Common reasons are no prescription, an investigational medicine, a route the destination country does not allow, or handling that cannot be guaranteed.
What can I do if the medicine is investigational?
Ask your doctor about clinical trials and the manufacturer's expanded-access program. In the US, the physician, an IRB and the company must all agree.
Does Reserve Meds ever decline requests?
Yes. Our terms keep the right to decline, and when we do, we explain why and what other routes may exist.
Is treatment abroad an option?
Sometimes. The US CDC advises checking the clinician's qualifications, the facility's credentials and plans for follow-up care.
Sources for these answers: [1, 2, 6]
Sources
All sources were opened and checked on 18 October 2026. Rules and labels change, so the treating hospital or regulator confirms the current position before anything is filed.
- US FDA: How to Buy Medicines Safely From an Online Pharmacy (content current as of 2 January 2025) (accessed 18 October 2026)
- US FDA: Expanded Access, Information for Patients (accessed 18 October 2026)
- US FDA: Expanded Access (content current as of 1 October 2026) (accessed 18 October 2026)
- European Medicines Agency: Compassionate use (accessed 18 October 2026)
- NHRA Bahrain: Circular No. (41) of 2020, procedures for importing non-registered medicines (accessed 18 October 2026)
- US CDC Travelers' Health: Medical Tourism, Getting Medical Care in Another Country (accessed 18 October 2026)
- World Health Organization: Substandard and falsified medical products (fact sheet) (accessed 18 October 2026)
Related
- US expanded access (compassionate use)
- Medicine not registered: the options
- Questions to ask before you start
- Checklist for patients and families
- Reserve Meds vs Everyone.org: which fits a Gulf family?
- Answers to common access questions
- اقرأ هذه الصفحة بالعربية
This page is general information, not medical or legal advice. It does not replace advice from your own doctor or the regulator.